ACTRN12609000983202尚未招募2 期
Exenatide in acute ischemic stroke - effect on cerebral inflammation and glucose homeostasis
Monash university eastern clinical research unit0 个研究点目标入组 10 人开始时间: 2009年11月13日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 85 Years（—）
- 性别
- All
入选标准
- •18 – 85 years
- •Stroke symptom onset within 12 hours
- •Measurable neurological deficit (National Institute of Health Stroke Scale [NIHSS] 4-22)
- •Blood sugar level on admission = 3mmol/L
- •Pre-morbid Modified Rankin Scale 0-2
- •Computed Tomography (CT) Scan Brain excluded intracerebral haemorrhage
排除标准
- •Unlikely to survive beyond 14 days
- •Pregnant (known or suspected) or breast feeding
- •Previous clinical stroke in the last one month
- •Concomitant inflammatory disease
- •Diabetic patients already on Exenatide or combination insulin and oral hypoglycaemic agents
- •Have a known allergy or hypersensitivity to exenatide.
- •Past history of pancreatitis or evidence of active pancreatitis.
- •Patients with other severe gastrointestinal disease like gastroparesis and dumping syndrome
- •Patients with end stage renal disease (creatinine clearance < 30 ml/mt)
研究者
相似试验
尚未招募
2 期
Exenatide in acute ischemic stroke- a randomised controlled trialAcute ischemic strokeNeurological - Other neurological disordersStroke - IschaemicMetabolic and Endocrine - Other metabolic disordersHyperglycemiaACTRN12612000957897Monash University eastern clinical research unit50
Unknown
2 期
Trial of EXenatide in Acute Ischaemic StrokeAcute Ischemic StrokeNCT03287076Neuroscience Trials Australia350
Unknown
3 期
Effect of Additional Treatment With EXenatide in Patients With an Acute Myocardial Infarction (the EXAMI Trial)Patients With a First Acute Myocardial Infarction to be Treated With Primary Percutaneous Coronary Intervention (PCI).NCT01254123Amsterdam UMC, location VUmc40
招募中
2 期
Central nervous effects of Exenatide i.v. vs. NaCl 0.9% on regulation of hunger and satiety in obesity and type 2 diabetes: an fMRI study. Amendment 1: increase of dosageE66ObesityDRKS00000301niversität Leipzig20
已完成
不适用
Acute Candesartan Cilexetil Outcomes Stroke TrialAcute strokeCirculatory SystemStroke, not specified as haemorrhage or infarctionISRCTN76657275City Hospitals Sunderland NHS Foundation Trust (UK)50